Biovail forms committee to oversee Melnyk bid

Article Abstract:

Intentions of Biovail Corp., to go private are coming true, with a special committee being appointed, that will overlook buyout process and other related issues. The buyout of the company is estimated to be around more than $3 billion and was proposed by the chairman, Eugene Melnyk.

Strategy & planning, Planning, Company business planning, Management committees

---

Biovail to make `surprising' product announcement today

Article Abstract:

Mississauga-based drug company, Biovail Corp., is preparing a significant product announcement this morning. Although the company would not say what it was, it did confirm that the product line being acquired will be positive for the company.

Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Product information, Drugs

---

Buffeted Biovail ramps up bid to take drug maker private

Article Abstract:

The buyout plans of Eugene Melnyk, founder of Biovail Corp., are examined.

Melnyk, Eugene

Similar abstracts:

• Abstracts: Heinz's baby food fight comes to an end. Gerber drops bid to sell its baby food duty-free. Advertisers vow to fight magazine bill
• Abstracts: Canadian law firms compete to attract lucrative U.S. deals. Biovail hits SAC with $4.6-billion suit. Brain drain? Statscan calls it a wash
• Abstracts: Eaton's goes on a youth kick. Brick granted bottle reprieve
• Abstracts: Cable operators seek to sell stake in Primestar. Cable firms miss urban opportunity. AT&T rings in new year with cable rate hikes
• Abstracts: DeVille driven to capture bigger share of limo market. If Donald Trump had hauling to do

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.